Keyword: mRNA


Touchlight and GSK Sign License Agreement for DNA Production

24.07.2024 -

Touchlight, a UK-based custom development and manufacturing organization (CDMO) specializing in enzymatic DNA production, signed a license agreement with British...


Merck Partners with Afrigen Biologics on mRNA Vaccines

04.07.2024 -

German chemicals, pharmaceuticals and life sciences group Merck entered a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development...


Merck to Acquire Life Science Company Mirus Bio

24.05.2024 -

Merck has agreed to acquire US life sciences company Mirus Bio for $600 million (around €550 million) from Gamma Biosciences, a life sciences platform established by...


Wacker Expands Production Capacity for Biopharmaceuticals in San Diego

08.05.2024 -

Contract manufacturing and development organization (CDMO) Wacker Biotech US, a subsidiary of Germany’ Wacker Chemie specializing in the fermentative production of...


Wacker and Pantherna Collaborate on Production of mRNA Biopharmaceuticals

09.04.2024 -

German chemical group Wacker announced that its mRNA competence center in Halle is to produce an active ingredient based on mRNA and lipid nanoparticles (LNPs) supplied...

Chemistry & Life Sciences

The Future of mRNA Technology

20.03.2024 -

mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...


Lonza and Oxford Nanopore to Collaborate on mRNA Analysis

30.01.2024 -

Swiss contract development and manufacturing organization (CDMO) Lonza will collaborate with Oxford Nanopore Technologies, a UK-based company delivering a new generation...


Merck Presents Fully Integrated mRNA Services

26.09.2023 -

Merck is the first CTDMO (contract testing, development, and manufacturing organization) to offer an integrated service covering all critical phases of mRNA development...